Helicobacter pylori: gastric cancer and beyond.
D Brent Polk, Richard M Peek
https://pubmed.ncbi.nlm.nih.gov/20495574/Actively Recruiting
Led by Chinese PLA General Hospital · Updated on 2026-07-24
1500
Participants Needed
3
Research Sites
N/A
Total Duration
Researchers are evaluating the relationship between Helicobacter pylori H. pylori infection status, its distribution in the stomach, and pathological features with the biological behavior and long-term prognosis of early gastric cancer or related gastric neoplastic lesions in patients undergoing endoscopic submucosal dissection ESD. This observational study includes about 1500 participants from multiple centers, combining retrospective data from 1000 patients and prospective enrollment of 500 patients. The study addresses different H. pylori testing methods and their discordant results, aiming to clarify links between infection patterns, gastric cancer subtypes, and outcomes. Participants will not receive any experimental treatments instead, their care follows routine clinical practice including diagnostic tests like the 13C-urea breath test, serum antibody testing, pathological assessment of gastric tissue, and ESD treatment. The study groups include patients with current active H. pylori infection, persistent infection after eradication therapy, post-eradication without active infection, and those without evidence of infection. Clinical, endoscopic, pathological, and follow-up data will be collected to analyze H. pylori infection status, tissue distribution, mucosal changes, and cancer features. Participants involvement includes medical record reviews for retrospective patients and standard clinical evaluations for prospective patients. Assessments include H. pylori testing, lesion and tissue pathology, endoscopic findings, and long-term follow-up at 1, 2, and 3 years post-ESD and beyond. Outcomes measured include concordance of H. pylori tests, pathological features, recurrence rates, development of new gastric cancers, survival, and need for additional treatment. Follow-up methods involve outpatient visits, endoscopy, imaging, and telephone contact, with continuous monitoring of infection status and clinical outcomes.
CONDITIONS
Helicobacter Pylori Infection Status and Pathological Features for Predicting Gastric Cancer Biological Behavior and Prognosis: A Real-World Observational Study
H
He Zhou, PhD
S
Song Su, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Chinese PLA General Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or record review)
Duration - Varies by participant
Participants' medical records and routine clinical test results, including Helicobacter pylori tests and pathological assessments, are collected and reviewed. No experimental treatments are assigned; participants receive standard care including endoscopic submucosal dissection when indicated.
1 or more visits as part of routine clinical care
Duration - Up to 8 years after endoscopic submucosal dissection
Participants are monitored through follow-up visits, endoscopic exams, imaging, and telephone contacts to assess cancer outcomes, infection status, and need for additional treatment over several years.
Follow-up visits approximately every 6 to 12 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
D Brent Polk, Richard M Peek
https://pubmed.ncbi.nlm.nih.gov/20495574/Ichiro Oda, Haruhisa Suzuki, Satoru Nonaka...
https://pubmed.ncbi.nlm.nih.gov/23368986/Chinese PLA General Hospital
Lead Sponsor